Latest News - Johnson & Johnson
Top Corporates Hub
Johnson & Johnson
Johnson & Johnson (JNJ) Is One Of Jim Cramer’s Top Performing 2026 Stocks
05.07.2026 11:12
We recently published Jim Cramer’s Biggest Winners to Buy: Top 20 AI & Other Stocks He Got Right in 2026. Johnson & Johnson (NYSE:JNJ) is one of the stocks discussed by Jim Cramer. Healthcare giant Johnson & Johnson (NYSE:JNJ)’s shares are up by 68% over the past year and by 26% year-to-date. The firm reported […]
What A $750,000 Dividend Portfolio Actually Pays After Taxes, Medicare Premiums, And Reality
04.07.2026 17:09
A $750,000 portfolio at a 5% yield produces $37,500 a year. That is the number most dividend investors repeat. It is also the number they never actually deposit, because the IRS, Medicare, and the state they retired to all get paid first. Here is the gross math at four common yield levels on a $750,000 ... What A $750,000 Dividend Portfolio Actually Pays After Taxes, Medicare Premiums, And Reality
Sector Update: Healthcare Stocks Gain Thursday Afternoon
02.07.2026 17:42
Healthcare stocks were higher Thursday afternoon, with the NYSE Healthcare Index rising 2% and the S
The Portfolio That Could Put You in a New Car Every Year for Life
02.07.2026 17:13
The average new vehicle in the United States now costs roughly $49,000, with full-size pickups and many luxury models pushing far higher. That puts a quietly absurd idea within reach for people who think in terms of dividend income: building a portfolio that throws off enough cash every year to buy a new car without ... The Portfolio That Could Put You in a New Car Every Year for Life
What Would It Take to Give Away 10% of Your Income Every Year?
02.07.2026 16:15
Most spending benefits the person doing the spending. Charitable giving is different. People give because they believe in a cause, want to help others, improve their community, honor a loved one, or simply because generosity brings satisfaction. Many religious traditions encourage giving as well. In the Judeo-Christian tradition, a 10% tithe has been a longstanding ... What Would It Take to Give Away 10% of Your Income Every Year?
$500 a Month in These Stocks Will Generate $6,700 in Passive Annual Income
02.07.2026 15:02
Passive income is the paycheck that arrives whether you show up or not. Wages depend on a functioning employer, a healthy economy, and the continued willingness of both to keep the seat warm. Dividend income depends on a company writing a check every 90 days, and for a handful of blue chips, that check has ... $500 a Month in These Stocks Will Generate $6,700 in Passive Annual Income
The Portfolio That Pays For Your Bucket List
02.07.2026 14:47
Most bucket-list goals come with a price tag. Taking classes, hosting a family reunion, funding a scholarship for a grandchild, visiting your ancestors’ hometown in the Old Country, or finally seeing the Northern Lights all require money. Whatever form they take, the challenge is the same: how do you fund meaningful goals and experiences while ... The Portfolio That Pays For Your Bucket List
Is It Worth Investing in Johnson & Johnson (JNJ) Based on Wall Street's Bullish Views?
02.07.2026 13:30
According to the average brokerage recommendation (ABR), one should invest in Johnson & Johnson (JNJ). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
J&J or AbbVie: Which Stock Deserves a Place in Your Portfolio Now?
02.07.2026 12:56
JNJ and ABBV both offer solid long-term growth potential, but differences in diversification, pipeline strength and estimates may give one stock an edge.
Here’s What It Costs to Buy Back Your Fridays
02.07.2026 12:29
Most retirement calculators ask the wrong question. They assume the only goal is to stop working completely. Many workers would happily settle for something smaller: a three-day weekend, every week. For a worker earning roughly $80,000 a year, Fridays off are cumulatively worth about $16,000 annually. Replace that income and a five-day workweek becomes a ... Here’s What It Costs to Buy Back Your Fridays
3 Dividend Stocks to Buy Hand Over Fist in July
02.07.2026 12:00
Dividend investors entering July 2026 have a rare setup: Three of the market’s most reliable income stocks all delivered beat-and-raise first-quarter reports, all hiked their payouts in the past 12 months and all three are riding meaningful momentum into the back half of the year. The thesis is simple. When defensive cash-flow machines start outperforming, ... 3 Dividend Stocks to Buy Hand Over Fist in July
Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
01.07.2026 11:50
Bristol Myers Squibb trades at a deep discount, while Johnson & Johnson boasts higher margins and a broader reach. How do their financials and risks stack up?
Johnson & Johnson (JNJ) Stock After 73% One-Year Rally Is There Value Left
30.06.2026 13:08
If you are wondering whether Johnson & Johnson stock still offers value after a long run, this article explains what the current price might be implying about the company. The stock last closed at US$258.51, with returns of 11.8% over 7 days, 14.7% over 30 days, 24.7% year to date, 73.5% over 1 year, 72.7% over 3 years, and 76.1% over 5 years. These returns naturally raise questions about what is already priced in. Recent market attention on Johnson & Johnson has centered on broader...
Marley Health Launches to Build the Clinical Intelligence Layer for Proactive Pet Care
30.06.2026 10:00
Marley Health, a clinical intelligence company applying human healthcare science to pet health, today launched to support more proactive, data-informed veterinary care. The company is adapting AI, signal processing, biomarker development, and physiological measurement methods from human healthcare to veterinary medicine, using clinical data from studies conducted with veterinary patients at the Royal Veterinary College (RVC) and machine-learning expertise from the University of Oxford. Marley's
Citizens Sees Compelling Razor/Razor Blade Ecosystem As A Driver Of Sustainable Growth For Stereotaxis (STXS)
30.06.2026 02:04
Given its significant hedge fund backing and attractive upside potential, Stereotaxis, Inc. (NYSEAMERICAN:STXS) is one of the most promising robotics stocks. Stereotaxis, Inc. (NYSEAMERICAN:STXS) is navigating a pivotal product transition, with fresh regulatory wins and a transformational acquisition reshaping its commercial runway, even as near-term results reflect the costs of that transition. Last month, Stereotaxis, […]
Johnson & Johnson (JNJ) – Among the 10 Best Dividend Stocks to Buy for Passive Income
28.06.2026 03:35
Johnson & Johnson (NYSE:JNJ) is included among the 10 Best Dividend Stocks to Buy for Passive Income. On June 26, Guggenheim lifted its price recommendation on Johnson & Johnson (NYSE:JNJ) from $266 to $270. It reiterated a Buy rating on the shares. The firm updated its outlook ahead of the company kicking off Q2 earnings […]
Solvonis CEO on progress with potential alcohol use disorder treatment - ICYMI
27.06.2026 05:43
Solvonis Therapeutics PLC (LSE:SVNS, OTC:SLVNF) CEO, Anthony Tennyson, talked with Proactive about positive bridging pharmacokinetic (PK) data from the company's SVN-002 programme and what the results mean for its development strategy in alcohol use disorder. Tennyson explained that Solvonis...
J&J CEO Now Sees 'Line of Sight' to Double-Digit Growth for His $100 Billion Company. Here's Why Investors Should Pay Attention.
26.06.2026 10:35
Johnson & Johnson is a healthcare giant, but an opportunity to invest in the United States and a plethora of big products suggest it still has growth appeal.
Johnson & Johnson Advances Cardiac Ablation Technology in Europe with Availability of Dual Energy THERMOCOOL SMARTTOUCH SF Platform
25.06.2026 09:00
IRVINE, Calif., June 25, 2026--Johnson & Johnson advances cardiac ablation technology in Europe with availability of Dual Energy THERMOCOOL SMARTTOUCH SF Platform.
Jim Cramer on Intuitive Surgical: “Too Much Competition”
23.06.2026 14:31
Intuitive Surgical, Inc. (NASDAQ:ISRG) was among the stocks Jim Cramer discussed as he said that the Iran peace negotiations could trigger an oil glut, cool inflation, and pull interest rates down. Inquiring about the stock, a caller asked if it is a buy. Cramer replied: Too much competition, too much competition… Used to be king, […]